Biniyam Dagne
Overview
Explore the profile of Biniyam Dagne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diriba G, Alemu A, Yenew B, Ayano B, Hailu M, Buta B, et al.
J Glob Antimicrob Resist
. 2025 Feb;
PMID: 39988072
Objectives: To estimate the proportion of second-line anti-tuberculosis drug resistance among multidrug-resistant tuberculosis (MDR-TB) patients in Ethiopia. Methodology: A laboratory-based prospective cross-sectional study was conducted at the National Tuberculosis Reference...
2.
Yenew B, Kebede A, Alemu A, Diriba G, Mehammed Z, Amare M, et al.
PLoS One
. 2024 May;
19(5):e0303460.
PMID: 38753615
Background: The emergence of drug-resistant tuberculosis (DR-TB) has been a major obstacle to global tuberculosis control programs, especially in developing countries, including Ethiopia. This study investigated drug resistance patterns and...
3.
Seid G, Alemu A, Tsedalu T, Dagne B
IJID Reg
. 2023 Sep;
8:173.
PMID: 37727822
No abstract available.
4.
Assefa G, Desta K, Araya S, Girma S, Hailu E, Mihret A, et al.
Tuberc Res Treat
. 2023 Apr;
2023:3291538.
PMID: 37032734
Background: Drug-resistant tuberculosis (TB) epidemic in high-TB-incidence countries, particularly Ethiopia, remains a significant challenge. As a result, we investigated the drug resistance, common gene mutation, and molecular characterization of mycobacterial...
5.
Seid G, Alemu A, Dagne B, Gamtesa D
PLoS One
. 2023 Feb;
18(2):e0279203.
PMID: 36795648
Background: Tuberculosis (TB) which is caused by Mycobacterium tuberculosis poses a significant public health global treat. Tuberculosis meningitis (TBM) accounts for approximately 1% of all active TB cases. The diagnosis...
6.
Seid G, Alemu A, Dagne B, Sinshaw W, Gumi B
J Clin Tuberc Other Mycobact Dis
. 2022 Nov;
29:100337.
PMID: 36425906
Background: The complex causes tuberculosis, a severe public health problem. Close contacts of someone who has active pulmonary tuberculosis were at a greater risk of contracting the disease. Despite the...
7.
Diriba G, Alemu A, Tola H, Eshetu K, Yenew B, Amare M, et al.
IJID Reg
. 2022 Oct;
5:97-103.
PMID: 36247095
Objective: This study aimed to determine the frequencies and trends of and rifampicin resistance among presumptive tuberculosis patients in Ethiopia, who were tested using the Xpert MTB/RIF assay between 2014...
8.
Diriba G, Alemu A, Tola H, Yenew B, Amare M, Eshetu K, et al.
IJID Reg
. 2022 Sep;
5:39-43.
PMID: 36176268
Background: The rise of drug-resistant tuberculosis (DR-TB) has presented a substantial challenge to the national tuberculosis (TB) control program. Understanding the epidemiology of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) could help clinicians...
9.
Sinshaw W, Kebede A, Bitew A, Tadesse M, Mehamed Z, Alemu A, et al.
Afr J Lab Med
. 2022 Sep;
11(1):1671.
PMID: 36091348
Background: There is limited information on the performance of the Xpert MTB/RIF test for diagnosis of smear-negative pulmonary tuberculosis (SNPT) and rifampicin resistance (RR) in the same-day diagnosis approach. The...
10.
Seid G, Alemu A, Tsedalu T, Dagne B
IJID Reg
. 2022 Jul;
4:97-104.
PMID: 35880002
Background: Tuberculosis (TB) is a global burden, and this is likely to remain the case due to a lack of adequate and accurate point-of-care diagnostic tests. Obtaining good-quality sputum from...